Trainee Involvement in ERCP Risk Score

CompletedOBSERVATIONAL
Enrollment

1,283

Participants

Timeline

Start Date

April 1, 2020

Primary Completion Date

September 30, 2021

Study Completion Date

January 1, 2022

Conditions
Bile Duct DiseasesPancreas Cancer
Interventions
PROCEDURE

ERCP

endoscopic retrograde cholangiopancreatography

Trial Locations (1)

Unknown

Colentina Clinical Hospital, Bucharest

Sponsors
All Listed Sponsors
collaborator

Policlinico Gemelli, Rome, Italy

UNKNOWN

collaborator

Cantacuzino Clinical Hospital, Bucharest, Romania

UNKNOWN

collaborator

Zadar Hospital, Zadar, Croatia

UNKNOWN

collaborator

University of Belgrade

OTHER

collaborator

UHC Zagreb, Zagreb, Croatia

OTHER_GOV

collaborator

Oxford University Hospitals NHS Trust

OTHER

collaborator

University of Colorado, Denver, USA

UNKNOWN

collaborator

Medical University, Sofia, Bulgaria

UNKNOWN

collaborator

Universitaire Ziekenhuizen KU Leuven

OTHER

collaborator

ISUL Hospital, Sofia, Bulgaria

UNKNOWN

lead

Clinical Hospital Colentina

OTHER

NCT04341909 - Trainee Involvement in ERCP Risk Score | Biotech Hunter | Biotech Hunter